Aziz RK - Search Results

1

Hospital Microbiome Variations As Analyzed by High-Throughput Sequencing.

ElRakaiby MT, Gamal-Eldin S, Amin MA, Aziz RK. ElRakaiby MT, et al. Among authors: aziz rk. OMICS. 2019 Sep;23(9):426-438. doi: 10.1089/omi.2019.0111. Epub 2019 Aug 8. OMICS. 2019. PMID: 31393213

2

Pharmacomicrobiomics: the impact of human microbiome variations on systems pharmacology and personalized therapeutics.

ElRakaiby M, Dutilh BE, Rizkallah MR, Boleij A, Cole JN, Aziz RK. ElRakaiby M, et al. Among authors: aziz rk. OMICS. 2014 Jul;18(7):402-14. doi: 10.1089/omi.2014.0018. Epub 2014 May 2. OMICS. 2014. PMID: 24785449 Free PMC article. Review.

3

Antibiotic Resistome: Improving Detection and Quantification Accuracy for Comparative Metagenomics.

Elbehery AH, Aziz RK, Siam R. Elbehery AH, et al. Among authors: aziz rk. OMICS. 2016 Apr;20(4):229-38. doi: 10.1089/omi.2015.0191. Epub 2016 Mar 31. OMICS. 2016. PMID: 27031878

4

Toward the Drug Factory Microbiome: Microbial Community Variations in Antibiotic-Producing Clean Rooms.

Hamdy AM, El-Massry M, Kashef MT, Amin MA, Aziz RK. Hamdy AM, et al. Among authors: aziz rk. OMICS. 2018 Feb;22(2):133-144. doi: 10.1089/omi.2017.0091. Epub 2017 Sep 5. OMICS. 2018. PMID: 28873001

5

Interview with Prof. Ramy K. Aziz, Cairo University. The Dawn of Pharmacomicrobiomics.

Aziz RK. Aziz RK. OMICS. 2018 Apr;22(4):295-297. doi: 10.1089/omi.2018.0041. OMICS. 2018. PMID: 29652572 No abstract available.

6

Determination of voriconazole and co-administered drugs in plasma of pediatric cancer patients using UPLC-MS/MS: A key step towards personalized therapeutics.

Al-Ghobashy MA, Kamal SM, El-Sayed GM, Attia AK, Nagy M, ElZeiny A, Elrakaiby MT, Nooh MM, Abbassi M, Aziz RK. Al-Ghobashy MA, et al. Among authors: aziz rk. J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Aug 15;1092:489-498. doi: 10.1016/j.jchromb.2018.06.043. Epub 2018 Jun 27. J Chromatogr B Analyt Technol Biomed Life Sci. 2018. PMID: 30008305

7

Drug pharmacomicrobiomics and toxicomicrobiomics: from scattered reports to systematic studies of drug-microbiome interactions.

Aziz RK, Hegazy SM, Yasser R, Rizkallah MR, ElRakaiby MT. Aziz RK, et al. Expert Opin Drug Metab Toxicol. 2018 Oct;14(10):1043-1055. doi: 10.1080/17425255.2018.1530216. Epub 2018 Oct 9. Expert Opin Drug Metab Toxicol. 2018. PMID: 30269615 Review.

8

Toxicomicrobiomics: Narrowing the Gap Between Environmental and Medicinal Toxicogenomics.

Aziz RK. Aziz RK. OMICS. 2018 Dec;22(12):788-789. doi: 10.1089/omi.2018.0183. OMICS. 2018. PMID: 30571608 Review. No abstract available.

9

Novel blaCTX-M variants and genotype-phenotype correlations among clinical isolates of extended spectrum beta lactamase-producing Escherichia coli.

Ramadan AA, Abdelaziz NA, Amin MA, Aziz RK. Ramadan AA, et al. Among authors: aziz rk. Sci Rep. 2019 Mar 12;9(1):4224. doi: 10.1038/s41598-019-39730-0. Sci Rep. 2019. PMID: 30862858 Free PMC article.

10

Comparative Genome-Scale Metabolic Modeling of Metallo-Beta-Lactamase-Producing Multidrug-Resistant Klebsiella pneumoniae Clinical Isolates.

Norsigian CJ, Attia H, Szubin R, Yassin AS, Palsson BØ, Aziz RK, Monk JM. Norsigian CJ, et al. Among authors: aziz rk. Front Cell Infect Microbiol. 2019 May 24;9:161. doi: 10.3389/fcimb.2019.00161. eCollection 2019. Front Cell Infect Microbiol. 2019. PMID: 31179245 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

114 results

Search Page